Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today?

Shares of biotechnology company United Therapeutics (NASDAQ: UTHR) jumped 13.6% in the afternoon session after a federal district court ruled that competitor Liquidia Corporation infringed patent claims covering United Therapeutics' inhaled treprostinil treatments.

Liquidia Corporation announced in a company press release that the U.S. District Court for the District of Delaware found claims 1 and 14 of U.S. Patent No. 11,826,327 to be valid and infringed by Liquidia's Yutrepia inhalation powder. The court invalidated the other asserted patent claims and ordered both companies, Liquidia and United Therapeutics, to submit proposed legal remedies within one week.

United Therapeutics' shares are not very volatile and have had only five moves greater than 5% over the last year. Moves this large are rare for United Therapeutics and indicate that the news significantly impacted the market's perception of the business.

The previous big move was six days ago, when the stock dropped 4% after Goldman Sachs initiated coverage with a Sell rating. Goldman Sachs analyst Andrea Newkirk began covering the biotechnology company with the negative rating. A Sell rating signals that the analyst expects the stock to perform worse than the broader market or its peers, which can prompt some investors to reduce their positions. New coverage from a major investment bank often draws attention because it adds a fresh perspective on the company's valuation and outlook.

United Therapeutics is up 9.5% since the beginning of the year, and at $543.86 per share, it is trading close to its 52-week high of $596.76 from May 2026. Investors who bought $1,000 worth of United Therapeutics' shares five years ago would now have an investment worth $2,947. Yahoo Finance reports.

🔌 Vicor Corporation Raises Q3 2026 Revenue Guidance. Stock Up in Pre-Market.

Vicor raised its Q3 sequential growth guidance from more than 20% to more than 30% due to increased royalties from the previously announced first non-exclusive license for Vertical Power Delivery (VPD).

Vicor designs, manufactures and markets modular power components and complete power systems based on a portfolio of patented technologies. Vicor licenses its patents to OEMs and hyperscalers seeking supply chain assurance, flexibility and scalability. Headquartered in Andover, Massachusetts, Vicor's modules and power system technology are used in high-performance computing, industrial, transportation, aerospace and defense applications. GlobeNewswire reports.

💾 Micron Just Blew Wall Street Away Again—Here's What's Next

Micron (MU) blew it out of the water on earnings day late Wednesday.

The main headline is that the memory chip maker beat sales and profit forecasts for the quarter, driven by voracious demand from the AI boom.

Guidance was also strong, except for margin comments on the earnings call, which may be contributing to a muted pre-market reaction.

But keep Micron's quarter in context.

Consider this: Micron added about $43 billion in sales in the most recent quarter compared with the year-ago quarter. That's massive. Operating margins expanded significantly across all business segments.

The market is forward-looking, so the race is on to predict Micron's results over the next 12 months. But don't lose sight of what the company is doing right now. Yahoo Finance reports.

🤖 What's Going on With AMD Stock Thursday?

Advanced Micro Devices Inc. (NASDAQ: AMD) is expanding beyond traditional chipmaking as it builds a broader AI ecosystem around processors, software, models and systems, while experts point to agentic AI and inference as new demand drivers for its CPUs and GPUs.

AMD stock gained almost 30% in September and almost 200% year-to-date, briefly pushing the company above a $1 trillion market value, fueled by artificial intelligence infrastructure demand. Benzinga reports.

✈️ Boeing Stock Jumps on $20 Billion Navy Fighter Jet Win
Boeing (BA) stock jumped 2% on Wednesday after the Pentagon selected the aerospace giant over rival Northrop Grumman (NOC) to develop the U.S. Navy's next-generation fighter jet.
The contract for the sixth-generation F/A-XX Strike Fighter is worth more than $20 billion for the full-scale development phase, according to the Pentagon.
The award gives Boeing contracts to develop next-generation fighter programs for both the U.S. Navy and Air Force.
In March 2025, the Air Force awarded Boeing the contract to develop its sixth-generation fighter, officially designated the F-47. Yahoo Finance reports.

🏢 MacKenzie Realty Capital (MKZR) Stock Climbs Over 21% After Hours: Here's Why

MacKenzie Realty Capital Inc. (NASDAQ: MKZR) shares jumped 21.37% to $1.59 in after-hours trading Wednesday after the California-based real estate investment trust reported its fiscal 2026 results and suspended its preferred share repurchase program.

The results cover the fiscal year ended June 30.

Revenue for the year was $20.01 million, down 9% from $22.06 million a year earlier.

Net operating loss narrowed 33% to $15.61 million. Net loss shrank 41% to $14.13 million from $23.97 million. Benzinga reports.

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) RZAI: Roze AI Inc.
Total gain: +94.74%

2) MEDS: DataMEDS AI, Inc.
Total gain: +36.28%

3) SDEV: Stablecoin Development Corporation
Total gain: +27.80%

4) ABAT: American Battery Technology Company
Total gain: +20.81%

5) GLUE: Monte Rosa Therapeutics, Inc.
Total gain: +9.81%

The closing price of the top three market percent gainers trading near or above $2 on Sep 30.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET). Stock Analysis reports.

1) RZAI: Roze AI Inc.
Total gain: +89.99%

The stock appeared to be moving on no notable news.

2) GOW: GOWell Energy Technology
Total gain: +75.69%

The stock appeared to be moving on no notable news.

3) TNON: Tenon Medical, Inc.
Total gain: +49.82%

The company announced the full commercial launch of its new titanium 3D- printed lateral screw as part of the SImmetry+ SI Joint Fusion System following the successful completion of the implant's Alpha launch. The limited Alpha launch, involving existing SImmetry users and new physicians, generated approximately $1.2 million (1) in incremental revenue for a period beginning in late Q4 2025 through Q3 2026. The Company plans to support anticipated demand for the SImmetry+ System by expanding its instrument set inventory as needed. Accessnewwire reports.

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

ACN

Accenture

Q4 2026

Before Market Open

Estimate: 3.180

Actual: 3.290

MKC

McCormick & Co

Q3 2026

Before Market Open

Estimate: 0.750

Actual: 0.860

AYI

Acuity

Q4 2026

Before Market Open

Estimate: 5.590

Actual: 5.770

Time (ET) / Report / Period

• 8:30 AM / Weekly Jobless Claims / Sept. 26
• 9:45 AM / US Manufacturing PMI / Sep
• 10:00 AM / ISM Report On Business Manufacturing PMI / Sep

“Know what you own, and know why you own it.”

– Peter Lynch

Sourced in: One Up on Wall Street.

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.

Copyright © TradeZero 2026. All rights reserved.